BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shapiro DD, Soeung M, Perelli L, Dondossola E, Surasi DS, Tripathi DN, Bertocchio JP, Carbone F, Starbuck MW, Van Alstine ML, Rao P, Katz MHG, Parker NH, Shah AY, Carugo A, Heffernan TP, Schadler KL, Logothetis C, Walker CL, Wood CG, Karam JA, Draetta GF, Tannir NM, Genovese G, Msaouel P. Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies. Cancers (Basel) 2021;13:6022. [PMID: 34885132 DOI: 10.3390/cancers13236022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Su Y, Hong AL. Recent Advances in Renal Medullary Carcinoma. IJMS 2022;23:7097. [DOI: 10.3390/ijms23137097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol 2022;18:361-77. [PMID: 35190716 DOI: 10.1038/s41581-022-00540-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Gupta S, Swanson AA, Erickson LA. Renal Cell Carcinoma With Combined Loss of Fumarate Hydratase and SMARCB1/INI-1. Mayo Clin Proc 2022;97:630-2. [PMID: 35246295 DOI: 10.1016/j.mayocp.2022.01.011] [Reference Citation Analysis]